SRP0713

PFTK1 (CDK14)/CYCLINY, Active

PRECISIO^® Kinase, recombinant

• Código UNSPSC: 12352202
• NACRES: NA.77

Propiedades

• recombinante: expressed in baculovirus infected Sf9 cells
• Ensayo: 70-95% (SDS-PAGE)
• Formulario: frozen liquid
• actividad específica: 2.0-3.5 nmol/min·mg (radiometric)
• mol peso: ~64 kDa (Cyclin Y); ~72 kDa (PFTK1 (CDK14))
• concentración: 0.1 μg/μL
• nº de acceso: NM_012395; NM_145012
• Condiciones de envío: dry ice
• temp. de almacenamiento: −70°C
• Información sobre el gen: human ... CCNY(219771) , CDK14(5218)

Descripción

Aplicación

Useful for Kinase assay and Western blot.

Acciones bioquímicas o fisiológicas

Recombinant human full-length PFTK1 (CDK14) and Cyclin Y (2-end) were co-expressed by Baculovirus in Sf9 insect cells using N-terminal GST tags. PFTK1 is a member of the CDC2 - related protein kinase family which is expressed primarily in the postnatal and adult nervous system ⁽¹⁾. PFTK1 is expressed at high levels in brain, pancreas, kidney, heart, testis, and ovary. PFTK1 amino acid residue ser119 is required for its interaction with all four 14-3-3 isoforms, while ser120 may contribute slightly to PFTK1 binding ⁽²⁾. PFTK1 acts as a cyclin-dependent kinase that regulates cell cycle progression and cell proliferation. Overexpression of PFTK1 predicts resistance to chemotherapy in patients with oesophageal squamous cell carcinoma.

Reconstitución

Formulated in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, with 25% glycerol.

Almacenamiento y estabilidad

Store in aliquots at -70°C. Avoid freeze/thaw cycles.

Información legal

PRECISIO is a registered trademark of Merck KGaA, Darmstadt, Germany

Información de seguridad

• Código de clase de almacenamiento: 10 - Combustible liquids
• Clase de riesgo para el agua (WGK): WGK 1
• Punto de inflamabilidad (°F): Not applicable
• Punto de inflamabilidad (°C): Not applicable